Activity-Dependent BDNF Transcription and LocalTranslation

The idea for an activity-dependent transcription of BDNF gene was first supported by the findings that BDNF mRNA expression in the hippocampus is dramatically increased in animals undergoing experimental seizure (Zafra et al. 1990; Ernfors et al. 1991; Isackson et al. 1991; Dugich-Djordjevic et al. 1992). Subsequently, the level BDNF mRNA has been shown to increase markedly by LTP-inducing tetanic stimulation, with little or no effects on other neurotrophins (Patterson et al. 1992; Castren et al. 1993; Dragunow et al. 1993;Kesslak et al. 1998; Morimoto et al. 1998). This observation has inspired the efforts to correlate BDNF mRNA expression with learning and memory (Falkenberg et al. 1992; Kesslak et al. 1998; Hall et al. 2000; Mizuno et al. 2000). Enriched environment also enhances BDNF gene expression (Young et al. 1999; Ickes et al. 2000; Zhao et al. 2001). In the visual cortex, the expression of BDNF, but not NGF, in the visual cortex is regulated by visual inputs (Castren et al. 1992; Schoups et al. 1995; Pollock et al. 2001), and monocular activity blockade elicits a striking decrease in BDNF mRNA and protein in the visual cortex corresponding the deprived eye (Bozzi et al. 1995; Rossi et al. 1999;Lein and Shatz 2000). Sensory stimulation of whiskers enhances the expression of BDNF in the barrel cortex (Rocamora et al. 1996; Nanda and Mack 2000). Other physiologically relevant stimuli, such as physical activity and running (Neeper et al. 1996; Oliff et al. 1998;Russo-Neustadt et al. 1999; Cirelli and Tononi 2000; Berchtold et al. 2001), dietary restriction (Lee et al. 2000), sleep and circadian rhythm (Bova et al. 1998; Liang et al. 1998; Berchtold et al. 1999;Cirelli and Tononi 2000), also appear to affect BDNF gene expression. Moreover, BDNF mRNA levels could be influenced under a variety of pathological conditions known to alter neuronal activity in the brain, including Alzheimer's (Phillips et al. 1991; Narisawa-Saito et al. 1996; Connor et al. 1997; Holsinger et al. 2000), ischemia (Lindvall et al. 1992; Kokaia et al. 1998; Miyake et al. 2002), depression (Kokaia et al. 1993; Kawahara et al. 1997), and stress (Smith et al. 1995;Smith and Cizza 1996; Ueyama et al. 1997).

Timmusk and colleagues discovered that in the rat genomic structures of BDNF, there are four promoters in front of four short 5′ exons, all of which are individually spliced onto a common 3′ exon encoding the entire prepro-BDNF protein (Metsis et al. 1993; Timmusk et al. 1993). Exon IV transcript is predominantly expressed in the lung and heart whereas exon I, II, III transcripts are mainly in the brain (Timmusk et al. 1993). These three transcripts exhibit differential spatial and temporal regulation, and respond differently to kainic acid-induced seizure (Falkenberg et al. 1993; Metsis et al. 1993; Timmusk et al. 1993, 1994a,b; Kokaia et al. 1994). Exon III-containing transcript is by far the most effectively regulated by neuronal activity in the hippocampus and cortex (Metsis et al. 1993; Lauterborn et al. 2000). To analyze the relative importance of the four promoters in vivo, Timmusk et al. generated transgenic mouse lines with individual promoters fused with a reporter gene (Timmusk et al. 1995). They confirmed that different promoters are responsible for tissue-specific distribution of the four transcripts. Moreover, different promoters are used to control lesion-induced BDNF expression in the sciatic nerve, or to upregulate BDNF transcription in neurons by KCl or kainate. The existence of multiple BDNF promoters may control BDNF gene expression at transcription, mRNA stability, translation, and subcellular distribution levels, and fulfill the different functions of BDNF (such as regulation of neuronal survival, differentiation, synaptic transmission, and plasticity).

At cellular levels, the expression of BDNF mRNA is enhanced when the non-NMDA-type glutamate receptor is activated (Zafra et al. 1990,1991;Lindefors et al. 1992; Lauterborn et al. 2000) and suppressed when GABAa receptor is activated (Lindholm et al. 1994; Berninger et al. 1995). Cholinergic afferent inputs to the cortex and hippocampus also increase the levels of BDNF mRNA (da Penha Berzaghi et al. 1993). An important finding was that the enhancement of BDNF gene expression requires an increase in intracellular calcium concentrations ([Ca²⁺]i) (Zafra et al. 1992; Ghosh et al. 1994; Sano et al. 1996), possibly by Ca²⁺ influx through L-type Ca²⁺ channels or NMDA receptors (Shieh et al. 1998; Tao et al. 1998; Tabuchi et al. 2000). Application of high K⁺ to cultured cortical neurons appears to selectively enhance exon III transcript without affecting those of other exons (Tao et al. 1998). Further characterization identified two elements in the promoter III involved in Ca²⁺-dependent BDNF expression—the novel Ca²⁺ responsive sequence 1 (CaRE1, −73~−64 bp) (Tao et al. 2002) and the cAMP responsive element (CRE, −40~−30 bp) (Shieh et al. 1998; Tao et al. 1998). Binding of CRE to CREB, which becomes newly activated by CaM kinase IV-dependent phosphorylation on Ser-133 on Ca²⁺ influx, is required for depolarization-induced BDNF transcription (Shieh et al. 1998; Tao et al. 1998). The transcription factor that binds to CaRE1, named CaRF, has been cloned recently and shown to be regulated in a Ca²⁺- and neuron-specific manner (Tao et al. 2002). Activity-dependent transcription of BDNF gene is therefore mediated by a mechanism that involves cooperation of CREB/CRE and CaRF/CaRE1.

Despite extensive studies, the functional significance of activity-dependent transcription of BDNF gene in synaptic plasticity is still unclear. Although BDNF is considered an immediate-early gene, the kinetics of the induction of BDNF transcription is quite slow (2–4 h) compared with prototype such as c-fos. The slow time course of transcription makes it less likely to mediate most forms of synaptic plasticity including early phase LTP (E-LTP). It offers, however, a mechanism that translates acute changes in synaptic activity to long-lasting alteration of synaptic physiology and morphology. For example, BDNF mRNA expression in the hippocampus is markedly increased 2–4 h after application of tetanic stimulation (Patterson et al. 1992;Morimoto et al. 1998). This time course correlates well with L-LTP, which is implicated in long-term memory (Abel et al. 1997; Miller et al. 2002; Villarreal et al. 2002; for review, see Kandel 2001). Inhibition of BDNF signaling, either by BDNF gene knockout or by the BDNF scavenger TrkB–IgG, markedly attenuates L-LTP induced by multiple tetani or forskolin exposure (Kang et al. 1997; Korte et al. 1998;Patterson et al. 2001). It is therefore tempting to speculate that the tetanus-induced BDNF expression in the hippocampus mediates L-LTP but not E-LTP. One way to test this hypothesis is to create a situation in which activity-dependent BDNF transcription is selectively prohibited while activity-independent BDNF transcription remains intact. This could perhaps be accomplished by generating a “knock-in” mouse line in which the wild-type promoter III is replaced with a mutant one.

Another issue that needs to be addressed is how activity-dependent BDNF transcription contributes to local and synapse-specific modulation. Transcription occurs in the cell body. A homogenous increase of BDNF mRNAs in the cell body may be of some use to regulate neuronal/synaptic activity of a local neuronal network, but this by no means ensures selectivity to any synapses made on the same neuron. One way to overcome this problem is to selectively target BDNF mRNA or protein to the dendrites of activity synapses. Translocation of mRNAs to dendrites for local translation is a new and attractive idea that has been proposed to mediate synapse specificity of hippocampal LTP (Steward and Schuman 2001). BDNF mRNA has been found in the dendrites of hippocampal pyramidal neurons (Dugich-Djordjevic et al. 1992; Wetmore et al. 1994;Crino and Eberwine 1996). An increase in neuronal activity as a consequence of high K⁺-induced depolarization facilitates the translocation of BDNF mRNA into the dendrites of cultured hippocampal neurons (Tongiorgi et al. 1997), but selective targeting of BDNF mRNA to active synapses has yet to be established. BDNF itself has been shown to induce dendritic targeting of BDNF mRNA (Righi et al. 2000). One must demonstrate, however, that local and activity-dependent secretion of BDNF could recruit BDNF mRNA to the active synapses. An alternative mechanism could be that BDNF mRNA is nonselectively transported to dendritic spines, but is trapped by synapses that undergo high-frequency transmission. This idea is quite similar to the “synaptic tagging” model for the synapse specificity of L-LTP (Frey and Morris 1997). In either dendritic targeting or dendritic trapping model, a key element is the local translation of BDNF mRNA.

Activity-Dependent BDNFSecretion

Most secretory proteins are initially synthesized from their respective mRNA as precursor proteins in the endoplasmic reticulum (ER) and subsequently translocated to a series of intracellular organelles including the Golgi complex, immature and mature secretory vesicles, and finally secreted into extracellular space (Halban and Irminger 1994). The precursor proteins could be cleaved by two enzymatic pathways, which contribute significantly to how the mature proteins are secreted. Cleavage by furin or furin-like enzymes occurs within the trans-Golgi network (TGN), and prefers the carboxy-terminal side of multibasic sites (Arg–X–Lys/Arg–Arg) (Hosaka et al. 1991; Dubois et al. 1995). This pathway is used for proteins that are secreted without any trigger (constitutive pathway) (Kelly 1985; Glombik and Gerdes 2000). In excitable cells, such as neurons and neuroendocrine cells, neuropeptides are cleaved by prohormone convertase 1 and 2 (PC1 and PC2) (Rouille et al. 1995). This pathway is used for proteins whose secretion is triggered by certain extracellular and intracellular signals (regulated pathway) (Kelly 1985; Glombik and Gerdes 2000). Neuropeptides are generally secreted through regulated pathway, whereas most growth factors are secreted through constitutive pathway. Neurotrophins are also synthesized in proforms, which could be cleaved by furin as well as PC1 at the same site. The secretion of neurotrophins could be either constitutive or regulated. Non-neuronal cells, such as fibroblasts and Schwann cells, cleave neurotrophins by furin and secrete these proteins constitutively (Bresnahan et al. 1990;Acheson et al. 1991; Seidah et al. 1996a,b). Abundant evidence indicates that neurotrophins can also be cleaved by PC1 (Seidah et al. 1996a; Mowla et al. 1999) and secreted in response to depolarization signals in neurons and neuroendocrine cells (Edwards et al. 1988;Blochl and Thoenen 1995; Blochl and Thoenen 1996; Goodman et al. 1996;Heymach Jr. et al. 1996; Canossa et al. 1997; Kruttgen 1998). It should be pointed out, however, that protease cleavage is not essential for neurotrophin secretion. Small but significant amounts of pro-neurotrophins can be secreted from neurons and the neuroendocrine AtT20 cells (Heymach Jr. et al. 1996; Mowla et al. 1999, 2001; Farhadi et al. 2000; Fahnestock et al. 2001). Hempstead and colleagues recently demonstrated that the proforms of NGF and BDNF can be secreted and cleaved extracellularly by plasmin and a number of metalloproteinases (Lee et al. 2002). Remarkably, they found that pro-NGF binds p75NR with high affinity, leading to p75NR-dependent cell death in cultured neurons, with minimal activation of TrkA. In contrast, the mature NGF prefers TrkA to p75NR, regulating cell survival and neuronal differentiation (Lee et al. 2002). These results suggest that the function of neurotrophins can be controlled by proteolytic cleavage, and pro- and mature forms of neurotrophins may bind to different receptors, eliciting entirely different biological effects.

Mechanisms underlying regulated secretion of neurotrophins have been studied in some detail. Secretion of neurotrophins transfected into the hippocampal neurons could be induced by a variety of stimuli including depolarization agents high potassium (KCl) and veratridine, excitatory transmitter glutamate, cholinergic agonist carbachol, and neurotrophins themselves (Blochl and Thoenen 1995). Initial experiments suggest a requirement for Na⁺ influx, because replacing Na⁺with N-methyl-D-glucamine (NMDG) prevented depolarization-induced NGF secretion (Blochl and Thoenen 1995). Subsequent analysis indicated that the secretion of NGF and BDNF is independent of Na⁺ influx, and the NMDG may by itself interfere with NGF secretion (Hoener 2000). Although whether neurotrophin secretion requires the influx of extracellular Ca²⁺ remains debatable (Goodman et al. 1996;Griesbeck et al. 1999; Hartmann et al. 2001), studies by Thoenen and colleagues strongly suggest that the secretion requires a rise of intracellular Ca²⁺ ([Ca²⁺]i) as a consequence of the activation of the IP3 receptors on ER membranes (Canossa et al. 1997; Griesbeck et al. 1999). IP3 is generated by phospholipse C-γ (PLC-γ), which is coupled to the neurotrophin receptors Trks and metabotropic glutamate receptors. Thus, activation of PLC-γ and the subsequent mobilization of Ca²⁺ from intracellular Ca²⁺ stores seem to be the major mechanisms mediating neurotrophin secretion initiated by neurotrophins or neurotransmitter glutamate (Canossa et al. 2001). Using a vaccinia virus expression system, Murphy and colleagues showed that BDNF is sorted into the regulated pathway whereas other neurotrophins are sorted primarily into the constitutive pathway in hippocampal neurons (Mowla et al. 1999;Farhadi et al. 2000). Interestingly, inhibition of furin-mediated cleavage shifts pro-NGF and pro-NT3 sorting into the regulated pathway (Mowla et al. 1999; Farhadi et al. 2000). Thus, whether a neurotrophin is directed to constitutive or regulated secretion may depend on the efficiency of furin-cleavage. Furthermore, overexpression of pro-NT3 or formation of NT3–BDNF heterodimer when the two precursors are co-expressed also results in regulated secretion of NT3, suggesting that NT3 could hijack the regulated pathway normally used by BDNF (Mowla et al. 1999; Farhadi et al. 2000).

Two criteria must be met if the secretion of BDNF is involved in activity-dependent and synapse-specific modulation—the secretion of neurotrophins should not only be regulated, but also be local and be controlled by specific patterns of neuronal activity. Data from a number of laboratories have clearly demonstrated that patterned electrical stimulation is far better than simple depolarization by KCl in inducing BDNF secretion in several neuronal populations, and the most effective stimulus appears to be the LTP-inducing tetanic stimulation (Balkowiec and Katz 2000; Lever et al. 2001; Gartner and Staiger 2002). It is therefore possible that BDNF is only secreted at sites that fire high-frequency action potentials. BDNF is detected in large, dense core vesicles of sensory neurons and in brain synaptosomes (Fawcett et al. 1997; Michael et al. 1997). Transfection experiments using BDNF–GFP (green fluorescence protein) fusion constructs demonstrate that BDNF is packaged into secretory vesicles that are transported to somatodendritic compartments and, to some extent, to axons (Haubensak et al. 1998; Moller et al. 1998; Kojima et al. 2001a). It is important to note that these BDNF–GFP fluorescence spots are often concentrated at the synaptic junctions, as indicated by co-localization with the presynaptic marker synapsin I and postsynaptic marker PSD95 (Haubensak et al. 1998; Kojima et al. 2001a). The fluorescent spots rapidly disappear in response to depolarization or high frequency stimulation, suggesting secretion of BDNF–GFP from the synaptically localized secretory vesicles (Hartmann et al. 2001; Kojima et al. 2001a). Furthermore, the postsynaptic secretion of BDNF–GFP on high-frequency presynaptic stimulation appears to depend on activation of postsynaptic glutamate receptors (Hartmann et al. 2001). Kojima showed recently that the BDNF–GFP could be induced to secrete at one set of dendritic branches by laser-directed photolysis of caged glutamate, whereas the BDNF–GFP spots in the nearby dendrites of the same neurons were not affected (Kojima et al. 2001b). These results further support the notion that BDNF secretion could be restricted locally to synapses that undergo high-frequency transmission. Secretion of BDNF-GFP from extra-synaptic dendrites, however, has also been observed.

In marked contrast to the experimental support for activity-dependent and perhaps local secretion of BDNF, nothing has been published so far that addresses the functional role of the regulated BDNF secretion. This is very difficult because functional study must be performed in a situation in which the regulated secretion of BDNF is specifically blocked without affecting its constitutive secretion. In a recent collaborative work, we were very fortunate to stumble on a situation just like that (Egan et al. 2003). The human BDNF gene contains one frequent and single nucleotide polymorphism (SNP)—a valine (val) to methionine (met) substitution in the pro region of BDNF protein. Rodent hippocampal neurons transfected with val–BDNF–GFP exhibited a punctate distribution pattern throughout the soma and neuronal processes, whereas those with met–BDNF–GFP showed large clusters in the peri-nuclear regions. Moreover, depolarization-induced secretion of met–BDNF was reduced significantly, while its constitutive secretion was not changed. In the hippocampus of human subjects with met–BDNF allele, there is a specific reduction in the levels of n-acetyl asparatate (NAA), a putative measure of neuronal integrity and synaptic abundance. Functional magnetic resonance imaging (fMRI) also revealed abnormal hippocampal activation during a memory task in these subjects. In a cohort of 641 subjects, the met/met genotype exhibited a specific impairment in hippocampus-dependent episodic memory, while hippocampus-independent cognitive functions were normal. These results represent the first demonstration of a role for BDNF in human hippocampal function, and suggest the importance of activity-dependent secretion of BDNF in learning and memory in vivo.

Activity-Dependent Modulation of BDNF ReceptorTrafficking

An alternative and equally attractive mechanism to constrain BDNF modulation to highly active synapses is the activity-dependent modulation of the responsiveness to BDNF. One way to achieve this is to increase the number of BDNF receptors on the cell surface. Treatment with depolarizing agents results in an increase in the expression of TrkB receptors on the plasma membranes of retinal ganglion cells and spinal neurons (Meyer-Franke et al. 1998). This may explain why BDNF regulation of the survival of retinal ganglion neurons requires depolarization by high K⁺ or glutamate agonists (Meyer-Franke et al. 1995). Importantly, the increase in surface expression of TrkB is very rapid and requires no protein synthesis, suggesting an activity-dependent recruitment of the receptor to the plasma membrane by translocation from intracellular stores (Meyer-Franke et al. 1998). In the hippocampus, tetanic stimulation, but not simple depolarization or low frequency stimulation, has been shown to facilitate the insertion of TrkB into the cell surface (Du et al. 2000). Immunofluorescence staining suggests that the electric stimulation facilitated the movement of TrkB from the intracellular pool to the cell surface, particularly on neuronal processes. This effect requires Ca²⁺influx through NMDA receptors or voltage gated Ca²⁺ channels and activation of Ca²⁺/calmodulin-dependent kinase II (CaMKII), a mechanism quite similar to activity-dependent insertion of AMPA type receptors into the postsynaptic membrane during hippocampal LTP (Hayashi et al. 2000). Inhibition of excitatory synaptic transmission blocks the effect of electric stimulation, suggesting that such regulation could occur very locally at active synapses. It seems that the activity-dependent insertion of TrkB receptor is independent of ligand binding (Du et al. 2000). A preferential elevation of TrkB receptor expression at highly active synapses could ensure local action of BDNF without affecting the nearby less active synapses.

Another way to ensure that active neurons/synapses are preferentially regulated by BDNF is the activity-dependent enhancement of the internalization of BDNF-receptor complex. Binding of BDNF to TrkB not only activates its tyrosine kinase and its downstream signaling pathways (Kaplan and Miller 2000; Patapoutian and Reichardt 2001), but also induces the endocytosis of the receptor (Ehlers et al. 1995;Grimes et al. 1996). Internalization of neurotrophin–Trk complex seems to be critical in signal transduction that initiates cell body responses to target-derived neurotrophins (Bhattacharyya et al. 1997;Riccio et al. 1997; Senger and Campenot 1997; Zhang et al. 2000). This is quite unusual because the internalization for most other growth factor receptors is to terminate the signaling process (Sorkin and Waters 1993). The neurotrophin–Trk complex is internalized through clathrin-mediated endocytosis, leading to the formation of a specialized vesicular compartment called signaling endosome (Grimes et al. 1996; Grimes et al. 1997; Beattie et al. 2000). The internalized Trk receptor remains tyrosine-phosphorylated and activated, with its extracellular domain bound to the ligand neurotrophin inside the signaling endosomes, and the intracellular domain tightly associated with a number of signaling molecules such as PLC-γ, PI3 kinase, and proteins of the Ras–MAP kinase pathway in the cytoplama of the responsive neurons (Grimes et al. 1996; Howe et al. 2001). Using three independent approaches, my laboratory has recently demonstrated that electric stimulation enhances the internalization of TrkB receptor in hippocampal neurons (Du 2001). This activity-dependent modulation of receptor internalization requires Ca²⁺ influx as well as the tyrosine kinase of the TrkB receptor. Neuronal activity has been shown to rapidly activate TrkB tyrosine kinase, but this was interpreted as a consequence of activity-dependent secretion of BDNF (Aloyz et al. 1999; Binder et al. 1999; Patterson et al. 2001). We found that the same electric stimulation and Ca²⁺ influx also directly enhances the TrkB kinase in these neurons. Inhibition of internalization had no effect on TrkB kinase, but inhibition of TrkB kinase prevents the modulation of TrkB internalization, suggesting that the activity-dependent receptor endocytosis is mediated by the receptor tyrosine kinase itself. The activity- and Ca²⁺-dependent modulation of TrkB tyrosine kinase and its internalization provides an alternative and physiologically relevant mechanism by which preferential regulation of active synapses could be achieved. It should be pointed out that the experiments on activity-dependent modulation of neurotrophin responsiveness described above were done in cultured neurons. Their relevance to the BDNF modulation of hippocampal synaptic plasticity in vivo has yet to be established.

Concluding Remarks

Although the concept of neurotrophic regulation of synaptic function and plasticity is now widely accepted, the underlying mechanisms remain poorly understood. An important but unresolved issue is the relationship between the activity and neurotrophic regulation of synapse development and plasticity. Neurotrophins are diffusible factors, whereas a key feature of synaptic plasticity is that modulation occurs at specific, active synapses. Thus, two questions must be addressed before neurotrophins can truly be regarded as mediators for activity-dependent synaptic plasticity. First, how could neurotrophins distinguish active versus inactive synapses? Second, how could diffusible neurotrophins regulate synaptic efficacy or connectivity in a local and synapse-specific manner? Studies in recent years demonstrated that neuronal activity regulates the transcription of BDNF gene, but this alone is unlikely to ensure synapse specificity attributable to the fact that transcription occurs in neuronal cell body. There is also evidence for activity-dependent regulation of the transport of BDNF mRNA into dendrites. Although these studies are promising, selective transport of the mRNA to active synapses has yet to be demonstrated. Furthermore, the significance of target mRNA transport remains unclear unless local translation of BDNF protein at active synapses can be proven. A more acceptable scenario is the activity-dependent local secretion of BDNF protein. Mechanisms for limited diffusion of BDNF protein must be in place to help confine secreted BDNF at synapses that undergo activity-dependent modifications. On the other hand, control of cellular responsiveness to neurotrophins by neuronal activity seems to be at least an equally plausible, if not more applicable, mechanism for neurotrophins to restrict their actions to active synapses. Two strategies have been demonstrated in cultured hippocampal neurons. One is a higher level of expression of the neurotrophin receptors on the cell surface of active neurons/synapses. The other is an activity-dependent control of the internalization of the neurotrophin-receptor complex, leading to an enhanced neurotrophin signaling. It remains to be tested whether these mechanisms actually work in vivo. Although these findings are exciting and promising, we are still in the early stage of understanding the relationship between neuronal activity and neurotrophins in activity-dependent synaptic plasticity. Careful studies should be carried out to elucidate whether these mechanisms are physiologically relevant to the neurotrophic regulation of synaptic plasticity in vivo. Taken together, understanding how neurotrophins could mediate activity-dependent plasticity in a local and synapse-specific manner represents an important direction for future research.